Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Net Income

Bottom-line profit after all expenses, interest, and taxes.

Aurora Cannabis Inc.TSX: ACB.TO

Net Income · Q4 FY2026 · quarter ended Mar 2026

Net income remains negative

Q4 FY2026 net income was -CA$56.9M, compared with -CA$24.56M a year earlier. Trailing-twelve-month net income was -CA$38.62M.

Context

  • Net income amounted to 38.0% of revenue in FY2026, up 37.5 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 4 analysts of -CA$26.04M (+78.6%) for the fiscal year ending Mar 2027, a step up from the -7753.0% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$56.9M-3226.2% QoQ
Last fiscal yearMar 2026
-CA$121.76M-7753.0% YoY
LTMMar 2026
-CA$38.62M-2527.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-131.7%+20.3%+152.0 pp
1 year-7753.0%+78.6%+7831.7 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the income statement

Latest · FY2026
(121.76M) CAD
Year-over-year change
-7753.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -2527.2% is the lowest of 8, against a peer median of +39.0%.
  • Net income amounts to 12.1% of revenue for ACB.TO, versus a peer median of 31.2%.
ACB.TO Competitors
Net Income for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$33.21M CAD+52.5%—20.9%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$30.97M USD+235.0%+1.4%60.8%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$8.81M USD+39.0%—17.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$25.21M CAD-249.3%—9.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$38.02M CAD-59.4%—1377.2%
ACB.TOAurora Cannabis Inc.LTM Mar 2026-CA$38.62M CAD-2527.2%—12.1%
TSND.TOTerrAscend Corp.LTM Mar 2026-$81.53M USD-6.2%—31.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$263.55M CAD+55.9%—84.8%
Peer median (excluding ACB.TO) —+39.0%+1.4%31.2%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.